Lab Reagents
Human IgG antibody Laboratories manufactures the rbd on spike protein reagents distributed by Genprice. The Rbd On Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike RBD. Other Rbd products are available in stock. Specificity: Rbd Category: On Group: Spike Protein
Spike Protein information
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His] |
VAng-Wyb7338-20g |
Creative Biolabs |
20 µg |
EUR 628 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His] |
VAng-Wyb7338-50g |
Creative Biolabs |
50 µg |
EUR 1105 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc] |
VAng-Wyb7339-100g |
Creative Biolabs |
100 µg |
EUR 1747 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc] |
VAng-Wyb7339-20g |
Creative Biolabs |
20 µg |
EUR 628 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc] |
VAng-Wyb7339-50g |
Creative Biolabs |
50 µg |
EUR 1105 |
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein. |
Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant |
P1530-10 |
Biovision |
10 µg |
EUR 156 |
Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant |
P1530-50 |
Biovision |
50 µg |
EUR 591 |
SARS-CoV-2 (COVID-19) Biotinylated Spike RBD Recombinant Protein |
10-205 |
ProSci |
0.1 mg |
EUR 626.75 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein |
10-304 |
ProSci |
0.1 mg |
EUR 527 |
Description: SARS-CoV-2 (COVID-19) Spike RBD + SD1 Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein |
20-232 |
ProSci |
0.1 mg |
EUR 605.75 |
Description: SARS-CoV-2 (COVID-19) Spike RBD domain Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike RBD Antibody (biotin) |
9087-biotin-002mg |
ProSci |
0.02 mg |
EUR 191.42 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
SARS-CoV-2 (COVID-19) Spike RBD Antibody (biotin) |
9087-biotin-01mg |
ProSci |
0.1 mg |
EUR 495.22 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; RBD), Recombinant |
P1529-10 |
Biovision |
10 µg |
EUR 196 |
Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; RBD), Recombinant |
P1529-50 |
Biovision |
50 µg |
EUR 591 |
SARS-CoV-2 (COVID-19) Spike RBD + SD1 +SD2 Recombinant Protein |
10-305 |
ProSci |
0.1 mg |
EUR 527 |
Description: SARS-CoV-2 (COVID-19) Spike RBD + SD1 +SD2 Recombinant Protein |
Human Osteonectin (ON) ELISA Kit |
RD-ON-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 478 |
Human Osteonectin (ON) ELISA Kit |
RD-ON-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 662 |